Atıf Formatları
Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

F. Icli Et Al. , "Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil," ONCOLOGY , vol.56, no.4, pp.297-300, 1999

Icli, F. Et Al. 1999. Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil. ONCOLOGY , vol.56, no.4 , 297-300.

Icli, F., Arican, A., Cay, F., AKBULUT, H., Dincol, D., Karaoguz, H., ... DEMİRKAZIK, A.(1999). Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil. ONCOLOGY , vol.56, no.4, 297-300.

Icli, F Et Al. "Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil," ONCOLOGY , vol.56, no.4, 297-300, 1999

Icli, F Et Al. "Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil." ONCOLOGY , vol.56, no.4, pp.297-300, 1999

Icli, F. Et Al. (1999) . "Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil." ONCOLOGY , vol.56, no.4, pp.297-300.

@article{article, author={F Icli Et Al. }, title={Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil}, journal={ONCOLOGY}, year=1999, pages={297-300} }